Consensus statement from European experts on the diagnosis, management, and treatment of multiple myeloma: from standard therapy to novel approaches-Reference-Cited by-同舟云学术

Consensus statement from European experts on the diagnosis, management, and treatment of multiple myeloma: from standard therapy to novel approaches

Published:2010-06-17 Issue:8 Volume:51 Page:1424-1443
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Engelhardt Monika,Kleber Martina,Udi Josefina,Wäsch Ralph,Spencer Andrew,Patriarca Francesca,Knop StefAn,Bruno Benedetto,Gramatzki Martin,Morabito Fortunato,Kropff Martin,Neri Antonino,Sezer Orhan,Hajek Rom,Bunjes Donald,Boccadoro Mario,Straka Christian,Cavo Michele,Polliack Aaron,Einsele Hermann,Palumbo Antonio

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10428194.2010.487959

Reference184 articles.

1. State of the art therapy in multiple myeloma and future perspectives

2. Characterization of in vitro growth of multiple myeloma cells

3. 160 years of multiple myeloma: Progress and challenges

4. Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adherence to the evidence-based recommendations in managing bone health, pain, and mobility of patients with multiple myeloma: a mixed method in the Palestinian healthcare system;BMC Cancer;2024-03-05

2. Factors associated with quality of life in caregivers of patients with multiple myeloma;Journal of Surgery and Medicine;2023-10-27

3. Patient and Caregiver Experience Decision Factors in Treatment Decision Making: Results of a Systematic Literature Review of Multiple Myeloma Decision Aids;Value in Health;2023-01

4. KD-PACE Salvage Therapy for Aggressive Relapsed Refractory Multiple Myeloma, Plasma Cell Leukemia and Extramedullary Myeloma;Clinical Lymphoma Myeloma and Leukemia;2021-08

5. Refractory anti-NMDAR encephalitis successfully treated with bortezomib and associated movements disorders controlled with tramadol: a case report with literature review;Journal of Neurology;2020-06-13